According to NRx Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -$30.15 M. In 2022 the company made an earning of -$39.76 M an increase over its 2021 earnings that were of -$93.45 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$30.15 M | -24.16% |
2022 | -$39.76 M | -57.46% |
2021 | -$93.45 M |